Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.668 USD | -0.30% | -10.09% | -26.79% |
Kurzporträt
Mitarbeiterzahl: 135
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25.10.15 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 07.05.18 |
Chief Tech/Sci/R&D Officer | - | 03.10.23 | |
Richard Aranda
CTO | Chief Tech/Sci/R&D Officer | 64 | 01.02.18 |
Christian Waage
ADM | Chief Administrative Officer | 57 | 01.08.17 |
Bob Smith
PRN | Corporate Officer/Principal | - | 05.12. |
Jeff Boerneke
LAW | General Counsel | - | 01.01.21 |
Deanna Weber
HRO | Human Resources Officer | - | 01.04.18 |
Caryn Peterson
LAW | General Counsel | 65 | 01.01.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25.10.15 |
Thomas Daniel
BRD | Director/Board Member | 69 | 01.01.18 |
Skye Drynan
BRD | Director/Board Member | - | 11.03. |
John Quisel
BRD | Director/Board Member | 53 | 28.11. |
Russell Cox
BRD | Director/Board Member | 60 | 19.12.18 |
Sandra Milligan
BRD | Director/Board Member | - | 10.06.21 |
Renée Galá
BRD | Director/Board Member | 52 | 19.12.18 |
Steven Nathan
BRD | Director/Board Member | - | 11.03. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 226 218 652 | 220 518 846 ( 97,48 %) | 0 | 97,48 % |
Unternehmenskontakt
Gossamer Bio, Inc.
3013 Science Park Road Suite 200
92121, San Diego
+858 684 1300
http://www.gossamerbio.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Gossamer Bio Services, Inc.
Gossamer Bio Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Gossamer Bio, Inc., Gossamer Bio Services, Inc. operates as an American biopharmaceutical company which discovers, develops and commercializes immunology-based therapeutics. The private company is located in the US. |
Pharmaceuticals: Major
|
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-26.79% | 151 Mio. | |
+1.51% | 42.59 Mrd. | |
+8.57% | 40.65 Mrd. | |
+49.22% | 40.57 Mrd. | |
-12.36% | 26.77 Mrd. | |
+8.92% | 24.81 Mrd. | |
-25.13% | 18.17 Mrd. | |
+29.17% | 12.05 Mrd. | |
-3.12% | 11.7 Mrd. | |
+6.35% | 11.1 Mrd. |
- Börse
- Aktien
- A2PCBS Aktie
- Unternehmen Gossamer Bio, Inc.